Publications by authors named "Larry Leon"

Claim this Profile
A
A Bayesian approach towards the identification of latent subgroups.
Ethan M Alt, Peter Yi Guan, Larry Leon, Amarjot Kaur, Yue Shentu

Stat Methods Med Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects.
Jingyi Lin, Yujie Zhao, X Gregory Chen, Margarita Donica, Larry Léon

Contemp Clin Trials· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory subgroup identification in the heterogeneous Cox model: A relatively simple procedure.
Larry F León, Thomas Jemielita, Zifang Guo, Rachel Marceau West, Keaven M Anderson

Stat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rejoinder to Letter to the Editor "The Hazards of Period Specific and Weighted Hazard Ratios".
Ray S Lin, Ji Lin, Satrajit Roychoudhury, Keaven M Anderson, Tianle Hu, Larry F Leon

Stat Biopharm Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.
David R Spigel, Jamie E Chaft, Scott Gettinger, Bo H Chao, Luc Dirix, Larry Leon

J Thorac Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of treatment effects in weighted log-rank tests.
Ray S Lin, Larry F León

Contemp Clin Trials Commun· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.
Corey J Langer, Mark A Socinski, Jyoti D Patel, Alan B Sandler, Joan H Schiller, Larry Leon

Am J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of bevacizumab exposure beyond disease progression in patients with non-small-cell lung cancer: analyses of the ARIES observational cohort study.
Larry Leon, Michael Kosty, Mohammad Jahanzeb, David Spigel, Antoinette J Wozniak

Pharmacoepidemiol Drug Saf· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study.
Michael P Kosty, Antoinette J Wozniak, Mohammad Jahanzeb, Larry Leon, Susan Fish

Target Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials.
Raymond U Osarogiagbon, Federico Cappuzzo, Tudor Ciuleanu, Larry Leon, Barbara Klughammer

Transl Lung Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study.
Thomas J Lynch, David R Spigel, Julie Brahmer, Neal Fischbach, Jennifer Garst, Larry Leon

J Thorac Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
If the ratio of hazards r(t)=λe(t)/λc(t) does not depend on time t then the proportional hazards assumption holds.
Larry Frank Leon, Bann-Mo Day, Xiaoping Sylvia Hu

J Thorac Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community setting.
Edward J Stepanski, Carolina Reyes, Mark S Walker, Sacha Satram-Hoang, Larry Leon

Pancreas· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab maintenance in patients with advanced non-small-cell lung cancer, clinical patterns, and outcomes in the Eastern Cooperative Oncology Group 4599 Study: results of an exploratory analysis.
Ariel Lopez-Chavez, Todd Young, Sophie Fages, Larry Leon, Joan H Schiller

J Thorac Oncol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model Checking Techniques for Assessing Functional Form Specifications in Censored Linear Regression Models.
Larry F León, Tianxi Cai

Stat Sin· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study.
Janice P Dutcher, Larry Leon, Judith Manola, David M Friedland, Bruce Roth

Cancer· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional form diagnostics for Cox's proportional hazards model.
Larry F León, Chih-Ling Tsai

Biometrics· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis